Source:http://linkedlifedata.com/resource/pubmed/id/12604504
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2003-5-8
|
pubmed:abstractText |
At present, the circulating bioactivity of insulin-like growth factor I (IGF-I) is estimated by immunological measurements of IGF-I levels. However, immunoassays ignore the modifying effects of the IGF-binding proteins (IGFBPs) on the interaction between IGF-I and the IGF-I receptor (IGF-IR). Therefore, we developed an IGF-I kinase receptor activation assay (KIRA) based on cells transfected with the human IGF-IR gene. The bioassay was sensitive (detection limit 0.08 microg/l), specific (cross-reactivity of insulin, insulin analogs, and proinsulin was <1%; IGF-II cross-reactivity was 12%), and accurate (within- and between-assay coefficients of variation <7 and <15%). The operational range of the assay (0.25-10.0 microg/l) allowed for determination of IGF-I bioactivity in serum from patients with, for example, growth hormone deficiency, type 1 diabetes, and acromegaly. Addition of IGFBPs dose dependently reduced the KIRA signal, whereas addition of IGF-II to preformed complexes (1:1 molar ratio) of IGF-I and IGFBP dose dependently increased IGF-I bioactivity by displacement of bound IGF-I. In conclusion, the KIRA will enable us to compare IGF-I bioactivity with existing immunological measurements of IGF-I in serum and, hopefully, to elucidate the factors that determine IGF-I bioactivity in vivo.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Buffers,
http://linkedlifedata.com/resource/pubmed/chemical/Human Growth Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin-Like Growth Factor Binding...,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin-Like Growth Factor I
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0193-1849
|
pubmed:author |
pubmed-author:ChenJian-WenJW,
pubmed-author:ChristiansenJens SandahlJS,
pubmed-author:De MeytsPierreP,
pubmed-author:FrystykJanJ,
pubmed-author:JessenNielsN,
pubmed-author:LarsenMaj BrittMB,
pubmed-author:LedetThomasT,
pubmed-author:LundStenS,
pubmed-author:OrskovHansH,
pubmed-author:WhittakerJonathanJ
|
pubmed:issnType |
Print
|
pubmed:volume |
284
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
E1149-55
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12604504-Acromegaly,
pubmed-meshheading:12604504-Adult,
pubmed-meshheading:12604504-Biological Assay,
pubmed-meshheading:12604504-Buffers,
pubmed-meshheading:12604504-Cross Reactions,
pubmed-meshheading:12604504-Diabetes Mellitus,
pubmed-meshheading:12604504-Dose-Response Relationship, Drug,
pubmed-meshheading:12604504-Human Growth Hormone,
pubmed-meshheading:12604504-Humans,
pubmed-meshheading:12604504-Insulin-Like Growth Factor Binding Proteins,
pubmed-meshheading:12604504-Insulin-Like Growth Factor I,
pubmed-meshheading:12604504-Male,
pubmed-meshheading:12604504-Phosphorylation,
pubmed-meshheading:12604504-Reference Values,
pubmed-meshheading:12604504-Reproducibility of Results,
pubmed-meshheading:12604504-Transfection
|
pubmed:year |
2003
|
pubmed:articleTitle |
A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum.
|
pubmed:affiliation |
Medical Department M, Aarhus University Hospital, DK-8000 Aarhus C, Denmark. wen@iekf.au.dk
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|